Patent Assignment
Reel/Frame 068067/0519
Assignment of Assignor's Interest
Recorded: 2024-07-24
Pages: 9
Assignors
WATSON, PAUL STEVEN
Executed: 2024-04-01
BERNER, BRET
Executed: 2022-11-08
NARAYAN, PADMA
Executed: 2024-03-23
CHEN, XIAOXIA
Executed: 2024-03-24
Assignee
SAGE THERAPEUTICS, INC.
215 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(3)
Formulations of 19-nor C3,3- Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
PCT:
PCT/US2021/042394 ↗
Formulations of 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
Application:
17/579,541 →
Publication:
US 2023/0057130
Formulations of 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
Application:
18/006,141 →
Publication:
US 2023/0285417
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2021
From: STUTZMAN, TODD ANTHONY; MENG, JIANING; WILKERSON, CAROLYN S.; RAMNIK JAIN, RAJ
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 057496/0665 →
Assignment of Assignor's Interest
Sep 16, 2021
From: CATALENT PHARMA SOLUTIONS, LLC
To: SAGE THERAPEUTICS, INC.
Reel/Frame 057496/0726 →
Assignment of Assignor's Interest
Feb 16, 2024
From: WATSON, PAUL STEVEN; BERNER, BRET; NARAYAN, PADMA; CHEN, XIAOXIA
To: SAGE THERAPEUTICS, INC.
Reel/Frame 066477/0814 →
Assignment of Assignor's Interest
Feb 16, 2024
From: STUTZMAN, TODD ANTHONY; MENG, JIANING; WILKERSON, CAROLYN S.; JAIN, RAJ RAMNIK
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 066478/0287 →
Assignment of Assignor's Interest
Feb 16, 2024
From: CATALENT PHARMA SOLUTIONS, LLC
To: SAGE THERAPEUTICS, INC.
Reel/Frame 066478/0740 →
Change of Name
May 13, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075610/0448 →